Key result
Enoxaparin and warfarin prophylaxis both achieve 0% thromboembolic disease after total knee arthroplasty.
Why the study?
Thromboembolic disease after knee arthroplasty occurs infrequently in Iran, but its incidence under prophylaxis was not well characterized in Southern Iran.
Does enoxaparin compared to warfarin prevent thromboembolic disease in patients undergoing total knee arthroplasty in Southern Iran?
RCT (n=100)
Randomized
Does enoxaparin compared to warfarin prevent thromboembolic disease in patients undergoing total knee arthroplasty in Southern Iran?
Thromboembolic disease is rare after total knee arthroplasty in Southern Iranian patients receiving either warfarin or enoxaparin prophylaxis, though enoxaparin may be associated with greater postoperative hemoglobin drops.
Answers are grounded in this paper and cite their sources.
Thromboembolic events appear rare with either prophylaxis in Southern Iran; hypothesis-generating and should not change practice.
BACKGROUND: Thromboembolic disease (TED) after knee arthroplasty occurs infrequently in Iran. The aim of this study was to examine the incidence of TED in patients with osteoarthritis undergoing knee replacement in Southern Iran while on prophylaxis. MATERIALS & METHODS: In a case series study from January to December 2012, 100 consecutive total knee arthroplasty (TKA) candidates were evaluated for TED by clinical evaluation and Doppler sonography preoperatively and 2 months postoperatively and by clinical evaluation one year after surgery. The patients in this study randomly received either warfarin or enoxaparin prophylactically. RESULTS: A total of 77 women and 23 men with mean age of 67 years (52-82 years) entered the study. The average hemoglobin drop of 2.7 g with warfarin and 3.3 with enoxaparin was observed. No case of TED, pulmonary embolus (PE), major bleeding, post-thrombotic syndrome, or hemarthrosis was observed. CONCLUSION: No clinically significant DVT was found using either enoxaparin or warfarin prophylaxis after TKA in Southern Iran. Relatively excessive postoperative bleeding was observed, particularly with enoxaparin.
No takes yet. Share an insight, caveat, or question.
Shahcheraghi et al. (2015) conducted an RCT in Osteoarthritis undergoing total knee arthroplasty (n=100). Enoxaparin vs. Warfarin was evaluated on Thromboembolic disease (TED). Enoxaparin and warfarin prophylaxis resulted in 0% incidence of thromboembolic disease after total knee arthroplasty, with average hemoglobin drops of 3.3 g and 2.7 g, respectively.
Synapse has enriched 10 related papers. Consider them for comparative context: